Overall rank by patents
#1,618
Across all tracked assignees
USPTO PatentsView assignee record - 255 granted patents across 55 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A23L (FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF).
The verdict
Givaudan holds 255 US patents across 55 technology areas, rank #1,618 of 50,000 tracked assignees.
Givaudan Sa has been granted 255 US utility patents between 2015 and 2025, placing Givaudan Sa at rank #1,618 across all assignees tracked by PlainPatent. This portfolio spans 55 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.6 claims per patent with primary concentration in A23L (FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF). As a Foreign Corporation, Givaudan Sa is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Givaudan sits between Nexans (256 patents, rank #1,614) and Z124 (255 patents, rank #1,622) - the closest US assignees by grant volume. The composite Innovation Score of 57.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 150 grants, compared with 105 in the 2015–2019 window, a +43% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Givaudan Sa's 13.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 55 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Givaudan Sa against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
NEXANS
256 patents
SEB S.A.
256 patents
STMicroelectronics Asia Pacific Pte Ltd
256 patents
BIOMERIEUX, INC.
255 patents
Memjet Technology Limited
255 patents
Merit Medical Systems, Inc.
255 patents
Nanjing University
255 patents
Z124
255 patents
Givaudan SA
255 patents
What this shows Givaudan holds 255 patents at rank #1,618, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #1,618 in granted patent volume.
Other assignees with the most granted patents in Givaudan's primary technology class.
Givaudan's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
57 Top 5% higher than 95% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 27 | 10.6% |
| 2016 | 15 | 5.9% |
| 2017 | 17 | 6.7% |
| 2018 | 18 | 7.1% |
| 2019 | 28 | 11.0% |
| 2020 | 36 | 14.1% |
| 2021 | 28 | 11.0% |
| 2022 | 23 | 9.0% |
| 2023 | 23 | 9.0% |
| 2024 | 22 | 8.6% |
| 2025 | 18 | 7.1% |
Top 15 of 55 technology areas
Overall rank by patents
#1,618
Across all tracked assignees
57.2 out of 100
How to use this portfolio
Givaudan's 255 grants land it in the top 5% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.